ATXS
Price
$12.80
Change
+$0.26 (+2.07%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
715.84M
49 days until earnings call
Intraday BUY SELL Signals
COYA
Price
$4.03
Change
-$0.61 (-13.15%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
97.09M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATXS vs COYA

Header iconATXS vs COYA Comparison
Open Charts ATXS vs COYABanner chart's image
Astria Therapeutics
Price$12.80
Change+$0.26 (+2.07%)
Volume$11.09K
Capitalization715.84M
Coya Therapeutics
Price$4.03
Change-$0.61 (-13.15%)
Volume$3.64K
Capitalization97.09M
ATXS vs COYA Comparison Chart in %
ATXS
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATXS vs. COYA commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and COYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (ATXS: $12.54 vs. COYA: $4.64)
Brand notoriety: ATXS and COYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 47% vs. COYA: 126%
Market capitalization -- ATXS: $715.84M vs. COYA: $97.09M
ATXS [@Biotechnology] is valued at $715.84M. COYA’s [@Biotechnology] market capitalization is $97.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCOYA’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • COYA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATXS and COYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while COYA’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 3 bearish.
  • COYA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than COYA.

Price Growth

ATXS (@Biotechnology) experienced а -5.00% price change this week, while COYA (@Biotechnology) price change was -9.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 05, 2026.

COYA is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($716M) has a higher market cap than COYA($97.1M). ATXS YTD gains are higher at: -4.202 vs. COYA (-20.000). COYA has higher annual earnings (EBITDA): -20.58M vs. ATXS (-136.51M). ATXS has more cash in the bank: 228M vs. COYA (28.1M). COYA has higher revenues than ATXS: COYA (3.99M) vs ATXS (706K).
ATXSCOYAATXS / COYA
Capitalization716M97.1M737%
EBITDA-136.51M-20.58M663%
Gain YTD-4.202-20.00021%
P/E RatioN/AN/A-
Revenue706K3.99M18%
Total Cash228M28.1M811%
Total Debt4.46MN/A-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCOYA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 23 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHISX66.390.60
+0.91%
BlackRock Health Sciences Opps Svc
NBRFX13.660.12
+0.89%
Neuberger Real Estate Tr
ALSMX15.63-0.07
-0.45%
Archer Multi Cap
GGGAX57.95-0.68
-1.16%
Gabelli Global Growth A
PGWAX97.56-1.61
-1.62%
Virtus Silvant Focused Growth A

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+0.24%
RGNX - ATXS
48%
Loosely correlated
-0.66%
SYRE - ATXS
47%
Loosely correlated
+5.17%
XENE - ATXS
46%
Loosely correlated
+3.02%
ORKA - ATXS
46%
Loosely correlated
+2.11%
REPL - ATXS
44%
Loosely correlated
-4.10%
More

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+0.43%
KNSA - COYA
42%
Loosely correlated
+2.49%
GANX - COYA
40%
Loosely correlated
-1.35%
ATXS - COYA
37%
Loosely correlated
+0.24%
SGMO - COYA
34%
Loosely correlated
-3.43%
SNDX - COYA
32%
Poorly correlated
+4.74%
More